Výsledky vyhledávání - "Kerstin Habersang"

Fast-Track Schedule for Vitamin D3 Substitution in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

Autor: Viola Poeschel, Martin Sökler, Andreas Neubauer, Andreas Viardot, Stephan Stilgenbauer, Ulrich Keller, Gerhard Held, Michael Pfreundschuh, Kerstin Habersang, Andreas Rank, Jonas Matthias Jabs, Bettina Altmann, Joerg Thomas Bittenbring, Heinz-Gert Hoeffkes, Marita Ziepert, Rolf Mahlberg

Publikováno v: Blood. 136:11-11

Vitamin D deficient patients suffering from diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP have lower overall survival. This especially applies for patients with vitamin D levels ≤8 ng/ml (Bittenbring et al. J Clin Oncol. 2014; 32:3242-8

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aabd8cd479392abf1cea4e2107bb1872
https://doi.org/10.1182/blood-2020-134944

Zobrazit plný text záznamu

Repeated responses of an elderly patient with high-risk myelodysplastic syndrome to sequential therapy with tipifarnib, 5-azacitidine, and decitabine

Autor: Kerstin Habersang, Isabel Möller, Rainer Haas, Andrea Kuendgen, Norbert Gattermann, Ulrich Germing, Sabine Blum

Publikováno v: Annals of Hematology. 88:1141-1144

Dear Editor, Patients with myelodysplastic syndromes (MDS) and a medullary blast count of more than 10% have a median survival of about 1 year. Intensive treatment approaches like induction chemotherapy and allogeneic stem cell transplantation offer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::903491d9a2b3fec2418583a288d87434
https://doi.org/10.1007/s00277-009-0730-x

Zobrazit plný text záznamu

Azygos Continuation Syndrome with Aneurysm of the Azygos Vein: CT and MR Appearances

Autor: Sylvaine Finken, Ulrich Mödder, Karin Lurz, Ludger Wilhelm Poll, J.-A. Koch, Kerstin Habersang

Publikováno v: Journal of Computer Assisted Tomography. 23:19-22

We present a case of azygos vein continuation with aneurysm of the azygos vein simulating a tumor in the right upper mediastinum. The dynamic CT examination initially showed a structure of malignant appearance during the early arterial phase. Further

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1226b2f36bd5196ba14f73952b5362d8
https://doi.org/10.1097/00004728-199901000-00005

Zobrazit plný text záznamu

Bone Marrow Fibroblasts from Children with Aplastic Anemia Exhibit Reduced Interleukin-6 Production in Response to Cytokines and Viral Challenge

Autor: Stefan Burdach, Dagmar Dilloo, Andreas Josting, Kerstin Habersang, Andreas Scheidt, Renata Vöhringer

Publikováno v: Pediatric Research. 38:716-721

Defects of the bone marrow microenvironment have been implicated in the pathogenesis of aplastic anemia (AA). We examined granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-6 production in bone marrow fibroblasts from five children with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ebbfed9d96284e0058d96e1e37ea52b
https://doi.org/10.1203/00006450-199511000-00014

Zobrazit plný text záznamu

Treatment of Poor Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia with a Combination of 5-Azacytidine and Valproic Acid

Autor: Ulrich Germing, Rainer Haas, Norbert Gattermann, Kerstin Habersang, Oliver G. Ottmann, Andrea Kuendgen, Gesine Bug, Barbara Hildebrandt, Ariane Dienst, Detlef Haase

Publikováno v: Blood. 112:3639-3639

The DNA demethylating agent 5-Azacytidine (5-Aza) is the first drug to achieve a survival benefit in patients with poor-risk MDS. In vitro, synergism with inhibitors of histone deacetylases has been described, and the clinical feasibility of combinin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::004d7f31b3e7de93cf0a78d9c7a89eca
https://doi.org/10.1182/blood.v112.11.3639.3639

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání